Recombinant Human CD70 Protein, Fc-tagged
Cat.No. : | CD70-891H |
Product Overview : | Recombinant Human CD70(Gln39-Pro193) fused with Fc tag at C-terminal was expressed in HEK293 cells. |
- Specification
- Gene Information
- Related Products
Description : | Cytokine that binds to CD27. Plays a role in T-cell activation. Induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells. |
Source : | HEK293 cells |
Tag : | Fc |
Form : | 1 x PBS, pH7.4, 10% glycerol. |
Molecular Mass : | 44 kDa |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Concentration : | >50 ug/mL as determined by microplate BCA method |
Gene Name : | CD70 CD70 molecule [ Homo sapiens ] |
Official Symbol : | CD70 |
Synonyms : | CD70; CD70 molecule; CD27LG, TNFSF7, tumor necrosis factor (ligand) superfamily, member 7; CD70 antigen; CD27L; CD27-L; CD27 ligand; Ki-24 antigen; surface antigen CD70; tumor necrosis factor ligand superfamily member 7; tumor necrosis factor (ligand) superfamily, member 7; CD27LG; TNFSF7; |
Gene ID : | 970 |
mRNA Refseq : | NM_001252 |
Protein Refseq : | NP_001243 |
MIM : | 602840 |
UniProt ID : | P32970 |
Products Types
◆ Lysates | ||
CD70-1303RCL | Recombinant Rat CD70 cell lysate | +Inquiry |
CD70-2710HCL | Recombinant Human CD70 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionAntibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) T-cell therapies are being developed to target CD70 in cancer.
CD70-targeted therapies can enhance the body's immune response against cancer cells and potentially lead to more effective treatments.
CD70 expression is often observed in Hodgkin's lymphoma and certain types of T-cell lymphomas.
Challenges include potential toxicities and finding the right balance to target CD70 effectively without harming normal immune functions.
Yes, there are ongoing clinical trials exploring CD70-targeted therapies for various cancer types.
Customer Reviews (3)
Write a reviewTheir collaboration, expertise, and customized solutions contribute to the successful execution of experiments, reliable data generation, and the advancement of scientific knowledge in the field.
the manufacturer's support is crucial for researchers using CD70 protein in trials.
These resources can enhance the efficiency and accuracy of experimental workflows and contribute to successful outcomes.
Ask a Question for All CD70 Products
Required fields are marked with *
My Review for All CD70 Products
Required fields are marked with *
Inquiry Basket